Registering a CAGR of 7.4% over the forecast period, the market value of Cardiology Surgical & Interventional Cardiology Devices is expected to reach US$ 45,754.1 million in the year 2027.
The report aspects discussed the profile of the top manufacturers of the global Cardiology Surgical & Interventional Cardiology Devices market. These aspects include the financial status of major companies, trending advancements, and the entire market scenario. Growth of the report has examined Cardiology Surgical & Interventional Cardiology Devices Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries. Because of the growing worldwide population, the demand for healthcare services has skyrocketed in recent years. Furthermore, due to the rise in the elderly population, the number of patients with cardiovascular and vascular disorders has been steadily rising. This has increased demand for equipment used to treat vascular and cardiovascular illnesses. Additionally, peripheral vascular devices and interventional cardiology can be used to treat a variety of heart and artery conditions. Additionally, technological developments have had a favourable impact on the market shares for peripheral vascular and interventional cardiology devices. Additionally, the market growth for peripheral vascular and interventional cardiology devices is positively impacted by the rapidly expanding healthcare sector in developing nations.
The global Cardiology Surgical & Interventional Cardiology Devices includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include, Abbott Cardiovascular, Plc Medical Systems, Biosense Webster, C.R. Bard, Cook Medical, Boston Scientific, Johnson & Johnson, Medtronic, Medtronic, Edwards Lifescience, Abbott, and others.
Johnson & Johnson Medical Devices Companies Announces Strategic Partnership with Microsoft to Further Enable its Digital Surgery Solutions
(January 10, 2022) The Johnson & Johnson Medical Devices Companies (JJMDC)* today announced that it will collaborate with Microsoft to further enable and expand JJMDC’s secure and compliant digital surgery ecosystem. The Microsoft Cloud will help JJMDC realize its vision of driving innovation that advances skills, improves workflow, and enhances surgical decision making for a better overall customer experience and improved patient and economic outcomes. JJMDC’s innovative medical technology exists across an ecosystem that includes next generation robotics, world-class instrumentation, advanced imaging and visualization, data and analytics, artificial intelligence, machine learning, and digital solutions. To mobilize the potential of these assets and make a clinical difference for patients, it is imperative to establish robust connectivity with, and between, all elements of the ecosystem with a seamless, interconnected network that meets surgeons where they are in their workflow and patients where they are in their healthcare journey.
By Type, it is segmented into
By Application, it is segmented into
In 2020, North America accounted for the greatest proportion of the global market for interventional cardiology devices thanks to rising R&D spending and effective reimbursement practices. Multiple rising markets and cutting-edge healthcare systems are also fueling the market's expansion. The market for interventional cardiology equipment is also being driven by the rising prevalence of diabetes, which can result in cardiac disorders. According to the American Diabetes Association, 1.5 million instances of diabetes are recorded each year in the country. Additionally, the US government's escalating efforts to establish an effective healthcare system have a positive impact on the market's expansion.
The Cardiology Surgical & Interventional Cardiology Devices Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Cardiology Surgical & Interventional Cardiology Devices Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Scope of the Report covers Cardiology Surgical & Interventional Cardiology Devices Market with a detailed analysis of the overall scenario for the market. It also highlights the business participants’ environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background, and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Cardiology Surgical & Interventional Cardiology Devices Market analysis report as it has vital details to provide about regional markets and expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how the worldwide market is working through efficient information graphics.
Report Attributes | Report Details |
Report Title | Cardiology Surgical & Interventional Cardiology Devices Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Abbott Cardiovascular, Plc Medical Systems, Biosense Webster, C.R. Bard, Cook Medical |
Forecast Period 2022 to 2027 CAGR | CAGR of 7.4% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Abbott Cardiovascular, Plc Medical Systems, Biosense Webster, C.R. Bard, Cook Medical, Boston Scientific, Johnson & Johnson, Medtronic, Medtronic, Edwards Lifescience |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 137 |
Customization Available | Yes, the report can be customized as per your needs |
Frequently Asked Questions
What is the study period of this market?
The Cardiology Surgical & Interventional Cardiology DevicesMarket is studied from 2017 - 2027.
What is the growth rate of the Cardiology Surgical & Interventional Cardiology Devices Market?
The Cardiology Surgical & Interventional Cardiology Devices Market is growing at a CAGR of 7.4% over the next 5 years.
Who are the key players in Cardiology Surgical & Interventional Cardiology Devices Market?
Abbott Cardiovascular, Plc Medical Systems, Biosense Webster, C.R. Bard, Cook Medical, Boston Scientific, Johnson & Johnson, Medtronic, Medtronic, Edwards Lifescience
What regions does this Cardiology Surgical & Interventional Cardiology Devices Market report cover?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Cardiology Surgical & Interventional Cardiology Devices Market?
Open-Heart Surgery, Off-Pump Heart Surgery, Minimally Invasive Heart Surgery
What are the major end-use applications of Cardiology Surgical & Interventional Cardiology Devices Market?
Hospitals, Clinics, Others
All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.